INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Centene Corporation of Class Action Lawsuit and Upcoming Deadlines - CNC
Werte in diesem Artikel
NEW YORK, July 22, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Centene Corporation ("Centene" or the "Company")(NYSE: CNC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
The class action concerns whether Centene and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
You have until September 8, 2025, to ask the Court to appoint you as Lead Plaintiff for the class if you purchased or otherwise acquired Centene securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com.
[Click here for information about joining the class action]
On July 1, 2025, Centene announced that it "is withdrawing its previous 2025 GAAP and adjusted diluted earnings per share (EPS) guidance, including the underlying guidance elements." Explaining its decision, Centene said that market growth in 22 states out of the 29 in its marketplace is not meeting expectations, and that the overall health risks in these states are much higher than what Centene had anticipated for its risk adjustment revenue calculations.
On this news, Centene's stock price fell $22.87 per share, or 40.37%, to close at $33.78 per share on July 2, 2025.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Danielle Peyton
Pomerantz LLP
dpeyton@pomlaw.com
646-581-9980 ext. 7980
View original content to download multimedia:https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-reminds-investors-with-losses-on-their-investment-in-centene-corporation-of-class-action-lawsuit-and-upcoming-deadlines---cnc-302510356.html
SOURCE Pomerantz LLP
Übrigens: Centene und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf Centene
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Centene
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Nachrichten zu Centene Corp.
Analysen zu Centene Corp.
Datum | Rating | Analyst | |
---|---|---|---|
20.10.2017 | Centene Outperform | BMO Capital Markets | |
05.04.2017 | Centene Buy | Deutsche Bank AG | |
08.02.2017 | Centene Overweight | Barclays Capital | |
07.02.2017 | Centene Overweight | Cantor Fitzgerald | |
20.06.2016 | Centene Overweight | Barclays Capital |
Datum | Rating | Analyst | |
---|---|---|---|
20.10.2017 | Centene Outperform | BMO Capital Markets | |
05.04.2017 | Centene Buy | Deutsche Bank AG | |
08.02.2017 | Centene Overweight | Barclays Capital | |
07.02.2017 | Centene Overweight | Cantor Fitzgerald | |
20.06.2016 | Centene Overweight | Barclays Capital |
Datum | Rating | Analyst | |
---|---|---|---|
15.06.2015 | Centene Hold | Deutsche Bank AG | |
15.06.2015 | Centene Mkt Perform | FBR Capital | |
28.04.2015 | Centene Mkt Perform | FBR Capital | |
11.02.2015 | Centene Neutral | UBS AG | |
15.12.2014 | Centene Hold | Deutsche Bank AG |
Datum | Rating | Analyst | |
---|---|---|---|
05.12.2006 | Update Centene Corp.: Sell | Goldman Sachs | |
12.06.2006 | Update Centene Corp.: Sell | Matrix Research |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Centene Corp. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen